

MétodosĮstudio retrospectivo, observacional, descriptivo. Eduardo Liceaga”, durante la realización de las “Ferias de la salud”. Presentar un panorama actual de onicomicosis en pacientes adultos mayores de los casos atendidos en un periodo de 2 años en el Hospital General de México “Dr. La perspectiva de aumento en el tiempo de vida del ser humano en la actualidad permite que diversas enfermedades aumenten su frecuencia, de éstas las alteraciones en la lámina ungueal, principalmente las onicomicosis pueden representar un riesgo en los adultos mayores debido a las patologías concomitantes que pueden complicar su tratamiento. Elderly patients should receive adequate health education and monitoring.


ConclusionsĪpproximately 9 out of 10 nail disorders in the elderly were onychomycosis many of these patients may present with comorbidities such as hypertension or diabetes mellitus, which often complicate treatment outcomes, affecting quality of life. On culture examination, Candida yeasts (24 patients, 46.2%), followed by Trichophyton rubrum (21 patients, 40.4%) were identified. In 125 patients (90.6%), filaments, yeasts or arthroconidia were observed. The average evolution was 12 years 60 patients (42.3%) denied previous treatments, and 32 (22.5%) used OTC medicines. The most common comorbidities in the remaining patients was arterial hypertension in 50 patients (36.2%) and diabetes mellitus in 49 (35.5%) the most common clinical type of OM was total dystrophic (87 patients, 63%), with involvement of the hallux of both feet (48 patients, 34.8%). Of these, 43 (31.2%) reported no concomitant diseases. ResultsĪ total of 138 patients were diagnosed with onychomycosis. Retrospective, observational, descriptive study. To determine the frequency of onychomycosis among elderly patients over a period of 2 years at the General Hospital of Mexico “Dr Eduardo Liceaga”. This fungal infection of the nails may represent a potential risk of complications among elderly due to the presence of concomitant diseases that can complicate their treatment. As life expectancy increases worldwide, so does the incidence of age-related pathologies, among them onychomycosis (OM).
